Check out our paper on Microbiology Support for Phage Therapy Trials
Toggle navigation
What We Do
About Us
Events & Press
Publications
Careers
Get In Touch
WHAT WE DO
Overview
Drug Discovery
Bacterial Repository
Clinical Scientific Expertise
Specialized Microbiology Laboratory Services
Clinical Development
Central Laboratory Microbiology Services
Clinical Scientific Expertise
Specialized Microbiology Laboratory Services
Regulatory Submissions
Antimicrobial Resistance Surveillance
Central Laboratory Microbiology Services
Clinical Scientific Expertise
Specialized Microbiology Laboratory Services
Commercialization
Antimicrobial Resistance Surveillance
Antimicrobial Voluntary Evaluation Program (AVEP)
Clinical Scientific Expertise
Manufacturers Interface and Performance Program (MIPP)
Specialized Microbiology Laboratory Services
Events & Press
January 10, 2022
Microbiology Support for Phage Therapy Trials: The Devils are in the Details
December 21, 2021
AMR Awareness Talks
November 18, 2021
Article – “New strategies for clinical trials are needed to combat AMR”
October 7, 2021
Introducing a New Antifungal Surveillance Program: Analysis of Resistance to Antifungals (ARIA) and Expanded Mycology Services at IHMA
October 7, 2021
10th Trends in Medical Mycology (TIMM-10)
September 29, 2021
IDWeek 2021
September 22, 2021
IHMA Opens Microbiology Reference Laboratory in Shanghai, China to Further Support Global Anti-Infective Product Discovery and Development
May 11, 2021
Article – “Why Antimicrobial Resistance is a Silent Pandemic”
April 30, 2021
Accreditation Committee of the College of American Pathologists (CAP) Awards Renewal of Accreditation to IHMA Site in Schaumburg, Illinois, USA
December 14, 2020
IHMA Expands their Global Support of Anti-infective Drug Development in India
Older posts
